not tagged
not tagged
['sarcoma', 'biomarker']
excellent participation of #paulhuang. the future for #ddr inhibitor therapy in #sarcoma is bright!!
further assessment in prospective randomized studies are required to identify #biomarkers of choice. #esmo22 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.